KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | CASTRO, Gilberto de | |
dc.contributor.author | KUDABA, Iveta | |
dc.contributor.author | WU, Yi-Long | |
dc.contributor.author | LOPES, Gilberto | |
dc.contributor.author | KOWALSKI, Dariusz M. | |
dc.contributor.author | TURNA, Hande Z. | |
dc.contributor.author | CAGLEVIC, Christian | |
dc.contributor.author | ZHANG, Li | |
dc.contributor.author | KARASZEWSKA, Boguslawa | |
dc.contributor.author | LAKTIONOV, Konstantin K. | |
dc.contributor.author | SRIMUNINNIMIT, Vichien | |
dc.contributor.author | BONDARENKO, Igor | |
dc.contributor.author | KUBOTA, Kaoru | |
dc.contributor.author | MUKHERJEE, Rinee | |
dc.contributor.author | LIN, Jianxin | |
dc.contributor.author | SOUZA, Fabricio | |
dc.contributor.author | MOK, Tony S. K. | |
dc.contributor.author | CHO, Byoung Chul | |
dc.date.accessioned | 2022-07-22T13:00:44Z | |
dc.date.available | 2022-07-22T13:00:44Z | |
dc.date.issued | 2021 | |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA | |
dc.identifier.citation | JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A390-A390, 2021 | |
dc.identifier.doi | 10.1136/jitc-2021-SITC2021.363 | |
dc.identifier.eissn | 2051-1426 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/47622 | |
dc.language.iso | eng | |
dc.publisher | BMJ PUBLISHING GROUP | eng |
dc.relation.ispartof | Journal for Immunotherapy of Cancer | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright BMJ PUBLISHING GROUP | eng |
dc.subject.wos | Oncology | eng |
dc.subject.wos | Immunology | eng |
dc.title | KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER | eng |
dc.type | conferenceObject | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Coréia do Sul | |
hcfmusp.affiliation.country | Letônia | |
hcfmusp.affiliation.country | China | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.country | Polônia | |
hcfmusp.affiliation.country | Turquia | |
hcfmusp.affiliation.country | Chile | |
hcfmusp.affiliation.country | Rússia | |
hcfmusp.affiliation.country | Tailândia | |
hcfmusp.affiliation.country | Ucrânia | |
hcfmusp.affiliation.country | Japão | |
hcfmusp.affiliation.countryiso | lv | |
hcfmusp.affiliation.countryiso | cn | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.affiliation.countryiso | pl | |
hcfmusp.affiliation.countryiso | tr | |
hcfmusp.affiliation.countryiso | cl | |
hcfmusp.affiliation.countryiso | ru | |
hcfmusp.affiliation.countryiso | th | |
hcfmusp.affiliation.countryiso | ua | |
hcfmusp.affiliation.countryiso | jp | |
hcfmusp.affiliation.countryiso | kr | |
hcfmusp.author.external | KUDABA, Iveta:Riga East Clin Univ, Latvian Oncol Ctr, Riga, Latvia | |
hcfmusp.author.external | WU, Yi-Long:Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China | |
hcfmusp.author.external | LOPES, Gilberto:Univ Miami, Dept Med Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA | |
hcfmusp.author.external | KOWALSKI, Dariusz M.:Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lung Canc & Chest Tumours, Warsaw, Poland | |
hcfmusp.author.external | TURNA, Hande Z.:Istanbul Univ, Dept Internal Med, Cerrahpasa Med Fac, Istanbul, Turkey | |
hcfmusp.author.external | CAGLEVIC, Christian:Inst Oncol Fdn Arturo Lopez Perez, Canc Res Dept, Santiago, Chile | |
hcfmusp.author.external | ZHANG, Li:Peking Union Med Coll Hosp, Beijing, Peoples R China | |
hcfmusp.author.external | KARASZEWSKA, Boguslawa:Przychodnia Lekarska KOMED, Konin, Poland | |
hcfmusp.author.external | LAKTIONOV, Konstantin K.:NN Blokhin Natl Med Res Ctr Oncol, Russian Federat NN Blokhin NMRCO, Minist Hlth, Fed State Budgetary Inst, Moscow, Russia | |
hcfmusp.author.external | SRIMUNINNIMIT, Vichien:Siriraj Hosp, Med, Bangkok, Thailand | |
hcfmusp.author.external | BONDARENKO, Igor:Dnipro State Med Univ, Oncol & Med Radiol Dept, Dnipro, Ukraine | |
hcfmusp.author.external | KUBOTA, Kaoru:Nippon Med Coll Hosp, Dept Pulm Med & Oncol, Tokyo, Japan | |
hcfmusp.author.external | MUKHERJEE, Rinee:Merck & Co Inc, Kenilworth, NJ USA | |
hcfmusp.author.external | LIN, Jianxin:Merck & Co Inc, Kenilworth, NJ USA | |
hcfmusp.author.external | SOUZA, Fabricio:Merck & Co Inc, Kenilworth, NJ USA | |
hcfmusp.author.external | MOK, Tony S. K.:Chinese Univ Hong Kong, State Key Lab Translat Oncol, Clin Oncol, Hong Kong, Peoples R China | |
hcfmusp.author.external | CHO, Byoung Chul:Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea | |
hcfmusp.contributor.author-fmusphc | GILBERTO DE CASTRO JUNIOR | |
hcfmusp.description.beginpage | A390 | |
hcfmusp.description.endpage | A390 | |
hcfmusp.description.issue | suppl 2 | |
hcfmusp.description.volume | 9 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000774877500352 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
relation.isAuthorOfPublication | 0df25c0f-1337-424e-b0f7-41d0fccb51fc | |
relation.isAuthorOfPublication.latestForDiscovery | 0df25c0f-1337-424e-b0f7-41d0fccb51fc |